About Us

Auritec Pharmaceuticals, Inc. is a rapidly growing research and development (R&D) company, specializing in innovative, extended release drug delivery systems.

Auritec was founded by Thomas J. Smith, MD. Dr. Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder and PI on key patents.  CDS, now Psivida Inc. (NASDQ - PSDV), is a successful device company specializing in ophthalmic extended release therapies.

We concentrate on improving treatments for life threatening or disabling diseases by utilizing proprietary technologies in drug delivery. Since its inception, Auritec has received over $20 million in NIH funding to develop sustained-release formulation for a number of serious or life-threatening diseases. With funding and multiple patents in place, Auritec is actively proceeding through its proof of concept phase with an eye toward licensing of its technology applications.